Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Dilip Davda has given "May Apply" recommendation to Paragon Fine And Speciality Chemicals IPO.
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 1 | 0 | 0 | 0 |
| % | 0.00 | 100.00 | 0.00 | 0.00 | 0.00 |
| Reviewer | Recommendation | Past Reviews |
|---|---|---|
| Dilip Davda | May Apply |  |
[Dilip Davda] PFSCL is engaged in the business of speciality chemical compounds. After static performance for FY21 and FY22, it posted bumper bottom lines on static top line. The sudden boost in its bottom lines for the past 15 months raises eyebrows as well as concern over the sustainability going forward. Based on annualized super earnings of FY24, the issue appears fully priced, discounting all near term positives. Well-informed investors may park moderate funds for medium to long term rewards. Read detail review...
Paragon Fine And Speciality Chemicals Limited peer comparison with similar listed entities. (Consolidated) (As on March 31, 2023)
| Company Name | EPS (Rs) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | |
|---|---|---|---|---|---|
| EPS Basic | EPS Diluted | ||||
| Paragon Fine And Speciality Chemicals Limited | 6.87 | 6.87 | 15.51 | 14.56 | 44.29 |
| Aether Industries Limited | 10.47 | 10.47 | 100.04 | 10.48 | |
| Anupam Rasayan India Ltd | 20.91 | 20.91 | 48.41 | 9.14 | |
| Bodal Chemicals Ltd. | 3.03 | 3.03 | 24.16 | 3.53 | |
| Deepak Nitrite Ltd | 62.47 | 62.47 | 31.94 | 20.83 | |
Notes:
(i)Source - All the financial information for the listed industry peers mentioned above is sourced from the audited financial results of the aforesaid companies for the year ended March 31, 2023, and stock exchange data dated August 23, 2023, to compute the corresponding financial ratios. For the Company, they have taken the Current Market Price as the issue price of equity shares.
(ii)Further, P/E Ratio is based on the current market price of the respective scrips.
(iii)The EPS, NAV, RoNW and Total Income of the Company are taken as per the Restated Financial Statement for the Financial Year 2022-23 as adjusted with the effect of Bonus Issue. (iv)NAV per share is computed as the closing net worth divided by the closing outstanding number of paid-up equity shares as adjusted with the effect of Bonus Issue.
(v) P/E Ratio of the peer company is based on the audited financial results of the company for the financial year 2023 and stock exchange data dated August 23, 2023.
(vi)RoNW has been computed as net profit after tax divided by closing net worth.
Paragon Fine And Speciality Chemicals IPO Reviews, analysis and views by popular members. Read Paragon Fine And Speciality Chemicals Limited IPO reviews by retail investors to find recommended ipo to buy.
Post Recommendation Manage Your IPO Reviews
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 1 | 0 | 0 | 0 |
| % | 100.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| SMEmitra |
Apply for Listing Gain at Cut-off Price Parameter - Score (0-5) |
Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
